-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636.O1.6 636. Myelodysplastic Syndromes—Basic and Translational Studies

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, AML, HSCs, Diseases, cellular interactions, Genetic Disorders, MDS, DNA damage, Biological Processes, Immune Disorders, Technology and Procedures, epigenetics, Cell Lineage, Lymphoid Malignancies, Study Population, genomics, Clinically relevant, Myeloid Malignancies, hematopoiesis, iron metabolism, NGS, metabolomics, molecular interactions, pathogenesis, pathways, signal transduction
Saturday, December 5, 2020: 2:00 PM-3:30 PM
Moderators:
Daniel Nowak, and Stephanie Halene, MD , Yale Univ. School of Medicine
Disclosures:
No relevant conflicts of interest to declare.
2:00 PM

Jakob Woerner1*, Yidi Huang, MS2*, Yimin Huang3*, Janet Wang, BS4*, Jesus M Hernández-Sánchez, PhD5*, Jaroslaw P. Maciejewski, MD, PhD6, Mehmet Koyuturk, PhD1*, Stephan Hutter, PhD7*, Torsten Haferlach, MD7 and Thomas Laframboise, PhD4*

1Case Western Reserve University, Cleveland
2Case Western Reserve University, Cleveland, OH
3Case Western Reserve University, Clevelans, OH
4Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH
5Universidad de Salamanca, IBSAL, Salamanca, Spain
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7MLL Munich Leukemia Laboratory, Munich, Germany

2:15 PM

Yang Mei, PhD1,2, Yijie Liu, PhD2, Xu Han, PhD2*, Jing Yang, PhD2* and Peng Ji, MD, PhD2

1College of Biology, Hunan University, Changsha, Hunan, China
2Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL

2:30 PM

David B. Beck, MD, PhD1*, Zhijie Wu, MD2*, Bhavisha A Patel, MD2, Marcela A Ferrada, MD3*, Keith A Sikora, MD4*, Amanda Ombrello, MD5*, Alina E. Dulau Florea, MD4*, Weixin Wang, Ph.D.6*, Emma M. Groarke, MD2, Shawn M. Burgess, PhD7*, Ivona A Aksentijevich, MD1*, Achim A Werner, PhD1*, Neal S. Young, MD2, Katherine Calvo, MD, PhD8, Daniel L Kastner, MD PhD9* and Peter C Grayson, MD10*

1National Institutes of Heath, Bethesda, MD
2Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3National Institutes of Heath, Bethesda, DC
4National Institutes of Health, Bethesda, MD
5National Human Genome Research Institute, NIH, National Institutes of Health, Bethesda, MD
6Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD
7NHGRI, NIH, Bethesda, MD
8Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
9National Human Genome Research Institute, National Institutes of Heath, Bethesda, MD
10NIAMS/NIH, Bethesda

2:45 PM

Monika M Kutyna, MSc1,2*, Li Yan A Wee, BSc (Hons)1,3*, Sharon Paton, BSc1,4*, Dimitrios Cakouros, PhD1,4*, Agnieszka Arthur, PhD1,4*, Rakchha Chhetri, MBBS1,3*, Andreas W Schreiber, PhD5,6*, Chung Hoow Kok, PhD, BSc1,7, Deepak Singhal, MBBS, MD, FRACP, FRCPA1,2,8, Daniel Thomas, MD, PhD9,10,11,12, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA1,11,13,14, David Campbell, PhD, B.M.B.S., F.R.A.C.S., F.A.Oth.A11,15*, Stan Gronthos, PhD1,4* and Devendra Hiwase, MBBS, MD, FRACP, FRCPA, PhD8,11,16

1Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
2Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
3Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
4Mesenchymal Stem Cell Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
5School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia
6ACRF Cancer Genomics Facility, SA Pathology, Adelaide, Australia
7Adelaide Medical School, The University of Adelaide, Adelaide, Australia
8Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
9Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
10Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
11Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
12Precision Medicine Theme, South Australian Health and Medical Research Instiute, Adelaide, SA, Australia
13Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
14Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
15Wakefield Orthopaedic Clinic, Calvary Wakefield Hospital, Adelaide, Australia
16Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia

3:00 PM

Hideki Makishima, MD, PhD1, Yasuhito Nannya, MD, PhD1, June Takeda, MD2*, Yukihide Momozawa, DVM, Ph.D3*, Ryunosuke Saiki, MD4*, Tetsuichi Yoshizato, MD, PhD4, Yoshiko Atsuta, MD, PhD5,6*, Yuka Iijima-Yamashita7*, Kenichi Yoshida, MD, PhD1*, Yuichi Shiraishi, PhD8*, Yasunobu Nagata, MD, PhD1*, Yusuke Shiozawa, MD, PhD9*, Makoto Onizuka, MD, PhD10, Kenichi Chiba11*, Hiroko Tanaka12*, Nobuyuki Kakiuchi, M.D.1*, Yotaro Ochi, MD1*, Hiroo Ueno, MD, PhD2*, Hidehiro Itonaga, MD, PhD13*, Yoshinobu Kanda, MD, PhD14, Masashi Sanada, MD15, Ayana Kon, MD, PhD1*, Yasushi Miyazaki, MD, PhD16, Keizo Horibe, MD, PhD15*, Maria Creignou17*, Magnus Tobiasson, MD18,19*, Hisashi Tsurumi, MD, PhD20, Senji Kasahara, MD, PhD21, Chantana Polprasert, MD22*, Eva Hellstrom Lindberg, MD, PhD23,24, Akifumi Kondo Takaori, MD, PhD25*, Toru Kiguchi, MD, PhD26*, Mario Cazzola27, Fumihiko Matsuda, MD, PhD28*, Kazuma Ohyashiki, MD, PhD29, Jaroslaw P. Maciejewski, MD, PhD30, Torsten Haferlach, MD31, Yoichiro Kamatani, MD, Ph.D32*, Michiaki Kubo, MD, Ph.D33*, Satoru Miyano, PhD34* and Seishi Ogawa, MD, PhD4,35

1Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
2Department of Pathology and Tumor Biology, Kyoto University, Kyoto, KYO, Japan
3Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
4Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
6Department of Healthcare Administration, Nagoya University, Nagoya, Japan
7Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan
8Center for Cancer Genomics and Advanced Therapeutics, National Cancer Center Research Institute, Tokyo, Japan
9Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan
10Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
11Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan
12Department of Integrated Data Science, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
13Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
14Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
15Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
16Atomic Bomb Disease Institute, Nagasaki University Hospital, Nagasaki, Japan
17Karolinska University Hospital, Stockholm, Sweden, Karolinska Institutet, Linköping, SWE
18Karolinska University Hospital, Stockholm, Sweden
19Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institute, Stockholm, Sweden
20Hematology, Gifu University Graduate School of Medicine, Gifu, Japan
21Hematology, Gifu Municipal Hospital, Gifu, Japan
22Division of Hematology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
23Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
24HERM, Dept. of Medicine, Huddinge, Karolinska Institute, and PO Hematology, Karolinska University Hospital, Stockholm, Sweden
25Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
26Department of Hematology, Chugoku Central Hospital, Fukuyama, HIR, Japan
27Department of Molecular Medicine, University of Pavia, Pavia, Italy
28Kyoto University Graduate School of Medicine, Kyoto, JPN
29Department of Advanced Cellular Therapy, Tokyo Medical University, Tokyo, Japan
30Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
31MLL Munchner Leukamie Labor Gmbh, Munchen, Germany
32Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
33RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
34The University of Tokyo, Human Genome Centre, Institute of Medical Science, Tokyo, Japan
35Department of Medicine, Center for Haematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden

3:15 PM

Timothy M Chlon, PhD1, Emily Stepanchick2*, Daniel Starczynowski, PhD3 and Kathleen Hueneman4*

1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital, Cincinnati, OH
2Cancer and Blood Diseases Institute, Cincinnati Chidlrens, Cincinnati, OH
3Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

*signifies non-member of ASH